The histopathology of drugs of abuse

Histopathology

Volumn 59, Issue 4, 2011, Pages 579-593

  Milroy, Christopher Mark ^a   Parai, Jacqueline Louise ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Amphetamine; Cocaine; Drug abuse; Heroin; Histopathology

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DIAMORPHINE; FENTANYL; KETAMINE; METHADONE; OPIATE; OXYCODONE;

AMYLOIDOSIS; AUTOPSY; BACTERIAL ENDOCARDITIS; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN INFARCTION; CARDIOMEGALY; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CYSTITIS; DISEASE TRANSMISSION; DRUG ABUSE; EMPHYSEMA; FOCAL GLOMERULONEPHRITIS; GASTROINTESTINAL TRACT; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; HYPERPYREXIA; INJECTION; INJECTION SITE REACTION; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; PIGMENTATION; PNEUMONIA; PRIORITY JOURNAL; PULMONARY ARTERY; RESPIRATORY EPITHELIUM; REVIEW; SUPPURATION; TESTIS FUNCTION; URINARY TRACT;

HUMANS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

CANNABIS; CANNABIS SATIVA;

EID: 80053976029     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03728.x     Document Type: Review

References (158)

1. Milroy CM. Substance misuse. Patterns and statistics. In Payne-James J, Byard RW, Corey TS, Henderson C eds. Encyclopedia of forensic and legal medicine. London: Elsevier, 2005; 4; 201-206.
2. Karch SB. Karch's pathology of drug abuse, 4th edn. London: CRC Press, 2009.
3. Drummer O, Forrest AR, Goldberger B, Karch SB, International Toxicology Advisory Group. Forensic science in the dock. BMJ 2004; 329; 636-637.
4. Passarino G, Ciccone G, Siragusa R, Tappero P, Mollo F. Histopathological findings in 851 autopsies of drug addicts, with toxicologic and virologic correlations. Am. J. Forensic Med. Pathol. 2005; 26; 106-116.
5. Ippolito SF, Spitz WU. Gastrointestinal hemorrhage from an internal jugular abscess in an intravenous drug addict. Am. J. Forensic Med. Pathol. 1990; 11; 158-159.
6. Krutchoff DJ, Eisenberg E, O'Brien JE, Ponzillo JJ. Cocaine induced dental erosions. N. Engl. J. Med. 1990; 322; 408.
7. Brand HS, Gonggrijp S, Blanksma CJ. Cocaine and oral health. Br. Dent. J. 2008; 204; 365-369.
8. Trimarchi M, Nicolai P, Lombardi D et al. Sinonasal osteocartilaginous necrosis in cocaine abusers: experience in 25 patients. Am. J. Rhinol. 2003; 17; 33-43.
9. Silvestre FJ, Perez-Herbera A, Puente-Sandoval A, Bagán JV. Hard palate perforation in cocaine abusers: a systematic review. Clin. Oral Invest. 2010; 14; 621-628.
10. Chow JM, Robertson AL, Stein RJ. Vascular changes in the nasal submucosa of chronic cocaine addicts. Am. J. Forensic Med. Pathol. 1990; 11; 136-143.
11. Daggett RB, Haghighi P, Terkeltaub RA. Nasal cocaine abuse causing an aggressive midline intranasal and pharyngeal destructive process mimicking midline reticulosis and limited Wegener's granulomatosis. J. Rheumatol. 1990; 17; 838-840.
12. Rachapalli SM, Kiely PD. Cocaine-induced midline destructive lesions mimicking ENT-limited Wegener's granulomatosis. Scand. J. Rheumatol. 2008; 37; 477-480.
13. Hirch CS. Dermatopathology of narcotic addiction. Hum. Pathol. 1972; 3; 37-54.
14. Rosen VJ. Cutaneous manifestations of drug abuse by parenteral injections. Am. J. Dermatopathol. 1985; 7; 79-83.
15. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin. Infect. Dis. 2000; 3; 579-581.
16. Galldiks N, Nolden-Hoverath S, Kosinski CM et al. Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin. Neurocrit. Care 2007; 6; 30-34.
17. Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. JAMA 1998; 279; 859-863.
18. Dhopesh VP, Taylor KR, Burke WM. Survey of hepatitis B and C in Addiction Treatment Unit. Am. J. Drug Alcohol Abuse 2000; 26; 703-707.
19. Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence-a comparison between injection and noninjection drug users in New York City. J. Urban Health 2004; 81; 20-24.
20. Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30years, 1994-2004. J. Urban Health 2007; 84; 436-454.
21. Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J. Urban Health 2008; 85; 309-322.
22. Burns SM, Brettle RP, Gore SM, Peutherer JF, Robertson JR. The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. J. Infect. 1996; 32; 53-62.
23. Centers for Disease Control and Prevention. Unexplained illness and death among injecting-drug users-Glasgow, Scotland; Dublin, Ireland; and England, April-June 2000. Morb. Mort. Wkly Rep. 2000; 49; 489-492.
24. Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among injecting-drug users-Scotland, Ireland, and England, April-June 2000. Morb. Mort. Wkly Rep. 2000; 49; 543-545.
25. Finn SP, Leen E, English L, O'Briain SD. Autopsy findings in an outbreak of severe systemic illness in heroin users following injection site inflammation: an effect of Clostridium novyi exotoxin? Arch. Pathol. Lab. Med. 2003; 127; 1465-1470.
26. Neugarten J, Gallo G, Buxbaum J, Katz L, Rubenstein J, Balwin D. Amyloidosis in subcutaneous heroin abusers ('skin poppers' amyloidosis') Am. J. Med. 1986; 81; 635-640.
27. Tan AU, Cohen AH, Levine BS. Renal amyloidosis in a drug user. J. Am. Soc. Nephrol. 1995; 5; 1653-1658.
28. Blair SD, Holcombe C, Coombes EN, O'Malley MK. Leg ischaemia secondary to non-medical injection of temazepam. Lancet 1991; 338; 1393-1394.
29. Coughlin P, Mavo A. Arterial consequences of recreational drug use. Eur. J. Vasc. Endovasc. Surg. 2006; 32; 389-396.
30. Del Giudice P. Cutaneous complications of intravenous drug abuse. Br. J. Dermatol. 2004; 150; 1-10.
31. Feeney CM, Briggs S. Crack hands: a dermatologic effect of smoking crack cocaine. Cutis 1992; 50; 193-194.
32. Koo J, Lee CS. Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment. Am. J. Clin. Dermatol. 2001; 2; 285-290.
33. Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J. Am. Acad. Dermatol. 2008; 59; 483-487.
34. Weidman AI, Fellner MJ. Cutaneous manifestations of heroin and other addictive drugs. Study and analysis. NY State J. Med. 1971; 71; 2643-2646.
35. Lange RA, Hillis D. Medical progress: cardiovascular complications of cocaine use. N. Engl. J. Med. 2002; 345; 351-358.
36. Karch SB, Billingham M. The pathology and etiology of cocaine-induced heart disease. Arch. Pathol. Lab. Med. 1988; 112; 225-230.
37. Mittleman RE, Wetli CV. Cocaine and sudden 'natural' death. J. Forensic Sci. 1987; 32; 11-19.
38. Karch SB, Green GS, Young S. Myocardial hypertrophy and coronary artery disease in male cocaine users. J. Forensic Sci. 1995; 40; 591-595.
39. Egred M, Davis GK. Cocaine and the heart. Postgrad. Med. J. 2005; 81; 568-571.
40. Dressler FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am. J. Cardiol. 1990; 65; 303-308.
41. Karch SB, Billingham ME. Coronary artery and peripheral vascular disease in cocaine users. Coron. Artery Dis. 1995; 3; 220-225.
42. Virmani R, Robinowitz M, Smialek JE, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am. Heart J. 1988; 15; 1068-1076.
43. Frishman WH, Del Vecchio A, Sanal S, Ismail A. Cardiovascular manifestations of substance abuse part 1: cocaine. Heart Dis. 2003; 5; 187-201.
44. Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am. J. Cardiol. 2007; 100; 1040-1043.
45. Karch SB, Billingham ME. Myocardial contraction bands revisited. Hum. Pathol. 1986; 17; 9-13.
46. Tazelaar HD, Karch SB, Stephens BG, Billingham ME. Cocaine and the heart. Hum. Pathol. 1987; 18; 195-199.
47. Hopster DJ, Milroy CM, Burns J, Roberts NB. Necropsy study of the association between sudden cardiac death, cardiac isoenzymes and contraction band necrosis. J. Clin. Pathol. 1996; 49; 403-406.
48. Jaffe BD, Broderick TM, Leier CV. Cocaine-induced coronary-artery dissection. N. Engl. J. Med. 1994; 330; 510-511.
49. Steinhauer JR, Caulfield JB. Spontaneous coronary artery dissection associated with cocaine use: a case report and brief review. Cardiovasc. Pathol. 2001; 10; 141-145.
50. Cohle SD, Lie JT. Dissection of the aorta and coronary arteries associated with acute cocaine intoxication. Arch. Pathol. Lab. Med. 1992; 116; 1239-1241.
51. Daniel JC, Huynh TT, Zhou W et al. Acute aortic dissection associated with use of cocaine. J. Vasc. Surg. 2007; 46; 427-433.
52. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J. Forensic Sci. 1999; 44; 359-368.
53. Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology. Addiction 2007; 102; 1204-1211.
54. Milroy CM, Clark JC, Forrest ARW. Pathology of deaths associated with 'ecstasy' and 'eve' misuse. J. Clin. Pathol. 1996; 49; 149-145.
55. Dressler FA, Roberts WC. Infective endocarditis in opiate addicts: an analysis of 80 cases studied at necropsy. Am. J. Cardiol. 1989; 63; 1240-1257.
56. Brown P, Levine D. Infective endocarditis in the injection drug user. Infect. Dis. Clin. N. Am. 2002; 16; 645-665.
57. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003; 89; 577-581.
58. Chambers HF, Morris DL, Tauber MG, Modin G. Cocaine use and the risk for endocarditis in intravenous drug users. Ann. Intern. Med. 1987; 106; 833-836.
59. Dettmeyer R, Friedrich K, Schmidt P, Madea B. Heroin-associated myocardial damages-conventional and immunohistochemical investigations. Forensic Sci. Int. 2009; 187; 42-46.
60. Morris RR. Human pulmonary histopathological changes from marijuana smoking. J. Forensic Sci. 1985; 30; 345-349.
61. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 1997; 112; 319-326.
62. Roth MD, Arosa A, Barsky SH, Kleerup EC, Simmons MS, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am. J. Respir. Crit. Care Med. 1998; 157; 928-937.
63. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alteratiosn in habitual smokers of marijuana, cocaine and/or tobacco. J. Nat. Cancer Inst. 1998; 90; 1198-1205.
64. Tashkin D. Smoked marijuana as a cause of lung injury. Arch. Chest Dis. 2005; 63; 93-100.
65. Tazelaar HD, Wright JL, Churg A. Desquamative interstitial pneumonia. Histopathology 2010; 21 September (epub ahead of print).
66. Gill A. Bong lung: regular smokers of cannabis show relatively distinctive histologic changes that predispose to pneumothorax. Am. J. Surg. Pathol. 2005; 29; 980-981.
67. Tashkin DP. Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? Can. Med. Assoc. J. 2009; 180; 797-798.
68. Tan WC, Lo C, Jong A et al. Marijuana and chronic obstructive lung disease: a population-based study. Can. Med. Assoc. J. 2009; 180; 814-820.
69. Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer: a systematic review. Arch. Intern. Med. 2006; 166; 1359-1367.
70. Aldington S, Harwood M, Cox B et al. Cannabis use and risk of lung cancer: a case-control study. Eur. Respir. J. 2008; 31; 280-286.
71. Berthiller J, Straif K, Boniol M et al. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J. Thorac. Oncol. 2008; 3; 1398-1403.
72. Aldington S, Harwood M, Cox B et al. Cannabis use and cancer of the head and neck: case-control study. Otolaryngol. Head Neck Surg. 2008; 138; 374-380.
73. Berthiller J, Lee YC, Boffetta P et al. Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. Cancer Epidemiol. Biomark. Prev. 2009; 18; 1544-1551.
74. Kissner DG, Lawrence WD, Selis JE, Flint A. Crack lung: pulmonary disease caused by cocaine abuse. Am. Rev. Respir. Dis. 1987; 136; 1250-1252.
75. Shesser R, Davis C, Edelstein S. Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine. Ann. Emerg. Med. 1981; 10; 213-215.
76. Adrouny A, Magnusson P. Pneumopericardium from cocaine inhalation. N. Engl. J. Med. 1985; 313; 48-49.
77. Goldberg RE, Lipuma JP, Cohen AM. Pneumomediastinum associated with cocaine abuse: a case report and review of the literature. J. Thorac. Imaging 1987; 2; 88-89.
78. Bailey ME, Fraire AE, Greenberg SD, Barnard J, Cagle PT. Pulmonary histopathology in cocaine abusers. Hum. Pathol. 1994; 25; 203-207.
79. Murray RJ, Smialek JE, Golle M, Albin RJ. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest 1989; 96; 1050-1053.
80. Klinger JR, Bensadoun E, Corrao WM. Pulmonary complications from alveolar accumulation of carbonaceous material in a cocaine smoker. Chest 1992; 101; 1171-1173.
81. Greenebaum E, Copeland A, Grewal R. Blackened bronchoalveolar lavage fluid in crack smokers. A preliminary study. Am. J. Clin. Pathol. 1993; 100; 481-487.
82. Singh B, Greenebaum E, Cole R. Carbon-laden macrophages in pleural fluid of crack smokers. Diagn. Cytopathol. 1995; 13; 316-319.
83. Milroy CM, Forrest AR. Methadone deaths: a toxicological analysis. J. Clin. Pathol. 2000; 53; 277-281.
84. Gardner AM. Aspiration of food and vomit. Q. J. Med. 1958; 27; 227-242.
85. Spain DM. Patterns of pulmonary fibrosis as related to pulmonary function. Ann. Int. Med. 1950; 33; 1150-1163.
86. Wendt VE, Puro HE, Shapiro J, Mathews W, Wolf PL. Angiothrombotic pulmonary hypertension in addicts. JAMA 1964; 188; 755-757.
87. Lewman LV. Fatal pulmonary hypertension from intravenous injection of methylphenidate (Ritalin) tablets. Hum. Pathol. 1972; 3; 67-70.
88. Tomashefski JF, Hirsch C. The pulmonary vascular lesions of intravenous drug abuse. Hum. Pathol. 1980; 11; 133-145.
89. Tomashefski JF Jr, Hirsch CS, Jolly PN. Microcrystalline cellulose pulmonary embolism and granulomatosis. A complication of illicit intravenous injections of pentazocine tablets. Arch. Pathol. Lab. Med. 1981; 105; 89-93.
90. Tomashefski J, Felo JA. The pulmonary pathology of illicit drug and substance abuse. Curr. Diagn. Pathol. 2004; 10; 413-426.
91. O'Donnell AE, Pappas LS. Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital. Chest 1988; 94; 251-253.
92. O'Donnell AE, Selig J, Aravamuthan M, Richardson MS. Pulmonary complications associated with illicit drug use. An update. Chest 1995; 108; 460-463.
93. Reisberg BE. Infective endocarditis in the narcotic addict. Prog. Cardiovasc. Dis. 1979; 22; 193-204.
94. Chan P, Ogilby JD, Segal B. Tricuspid valve endocarditis. Am. Heart J. 1989; 117; 1140-1146.
95. Tashkin DP. Pulmonary complications of smoked substance abuse. West. J. Med. 1990; 152; 525-530.
96. Wetli CV, Rao A, Rao VJ. Heroin body packing. Am. J. Forensic Med. Pathol. 1997; 18; 312-318.
97. Heinemann A, Miyaishi S, Iwersen S, Schmoldt A, Püschel K. Body-packing as cause of unexpected sudden death. Forensic Sci. Int. 1998; 92; 1-10.
98. Gill JR, Graham SM. Ten years of 'body packers' in New York City: 50 deaths. J. Forensic Sci. 2002; 47; 843-846.
99. Cawich SO, Downes R, Martin AC, Evans NR, Mitchell DI, Williams E. Colonic perforation: a lethal consequence of cannabis body packing. J. Forensic Leg. Med 2010; 17; 2692-2771.
100. Miller JS, Hendren SK, Liscum KR. Giant gastric ulcer in a body packer. J. Trauma 1998; 45; 617-619.
101. Lee HS, LaMaute HR, Pizzi WF, Picard DL, Luks FI. Acute gastroduodenal perforations associated with use of crack. Ann. Surg. 1990; 211; 15-17.
102. Sharma R, Organ CH Jr, Hirvela ER, Henderson VJ. Clinical observation of the temporal association between crack cocaine and duodenal ulcer perforation. Am. J. Surg. 1997; 174; 629-632.
103. Myers SI, Clagett GP, Valentine RJ, Hansen ME, Anand A, Chervu A. Chronic intestinal ischemia caused by intravenous cocaine use: report of two cases and review of the literature. J.Vasc. Surg. 1996; 23; 724-729.
104. Garfia A, Valverde JL, Borondo JC, Candenas I, Lucena J. Vascular lesions in intestinal ischemia induced by cocaine-alcohol abuse: report of a fatal case due to overdose. J. Forensic Sci. 1990; 35; 740-745.
105. Hoang MP, Lee EL, Anand A. Histologic spectrum of arterial and arteriolar lesions in acute and chronic cocaine-induced mesenteric ischemia: report of three cases and literature review. Am. J. Surg. Pathol. 1998; 22; 1404-1410.
106. Herrine SK, Park PK, Wechsler RJ. Acute mesenteric ischemia following intranasal cocaine use. Dig. Dis. Sci. 1998; 43; 586-589.
107. Muniz AE, Evans T. Acute gastrointestinal manifestations associated with use of crack. Am. J. Emerg. Med. 2001; 19; 61-63.
108. Paties C, Peveri V, Falzi G. Liver histopathology in autopsied drug-addicts. Forensic Sci. Int. 1987; 35; 11-26.
109. Theise ND, Bodenheimer HC, Ferrell LD. Acute and chronic viral hepatitis. In Burt AD, Portmann BC, Ferrell LD eds. MacSween's pathology of the liver, 5th edn. London: Churchill Livingstone, 2007; 399-441.
110. Kringsholm B, Christoffersen P. The nature and the occurrence of birefringent material in different organs in fatal drug addiction. Forensic Sci. Int. 1987; 34; 53-62.
111. Malmud N, Haymaker W, Custer P. Heat stroke. A clinicopathologic study of 125 fatal cases. Milit. Surg. 1946; 99; 397-449.
112. Gore I, Isaacson NH. The pathology of hyperpyrexia. Observations at autopsy in 17 cases of fever therapy. Am. J. Pathol. 1949; 25; 1029-1105.
113. Kew M, Bersohn I, Seftel H, Kent G. Liver damage in heatstroke. Am. J. Med. 1970; 49; 192-202.
114. Rubel LR, Ishak KG. The liver in fatal exhertional heatstroke. Liver 1983; 3; 249-260.
115. Ellis AJ, Wendon JA, Portmann B, Williams R. Acute liver damage and ecstasy ingestion. Gut 1996; 38; 454-458.
116. Osick LA, Lee TP, Pedemonte MB et al. Hepatic amyloidosis in intravenous drug abusers and AIDS patients. J. Hepatol. 1993; 19; 79-84.
117. Jaffe JA, Kimmel PL. Chronic nephropathies of cocaine and heroin abuse: a review. Clin. J. Am. Soc. Nephrol. 2006; 1; 655-667.
118. Rao TK, Nicastri AD, Friedman EA. Natural history of heroin-associated nephropathy. N. Engl. J. Med. 1974; 290; 19-23.
119. Cunningham EE, Zielezny MA, Venuto RC. Heroin-associated nephropathy. A nationwide problem. JAMA 1983; 250; 2935-2936.
120. Dubrow A, Mittman N, Ghali V, Flamenbaum W. The changing spectrum of heroin-associated nephropathy. Am. J. Kidney Dis. 1985; 5; 36-41.
121. Friedman EA, Tao TK. Disappearance of uremia due to heroin-associated nephropathy. Am. J. Kidney Dis. 1995; 25; 689-693.
122. do Sameiro Faria M, Sampaio S, Faria V, Carvalho E. Nephropathy associated with heroin abuse in Caucasian patients. Nephrol. Dial. Transplant. 2003; 18; 2308-2313.
123. Dettmeyer R, Wessling B, Madea B. Heroin associated nephropathy-a post-mortem study. Forensic Sci. Int. 1998; 95; 109-116.
124. Di Paolo N, Fineschi V, Di Paolo M et al. Kidney vascular damage and cocaine. Clin. Nephrol. 1997; 47; 298-303.
125. Scholes J, Derosena R, Appel GB, Jao W, Boyd MT, Pirani CL. Amyloidosis in chronic heroin addicts with the nephrotic syndrome. Ann. Intern. Med. 1979; 91; 26-29.
126. Manner I, Sagedal S, Røger M, Os I. Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure. Clin. Nephrol. 2009; 72; 224-228.
127. Richter RW, Challenor YB, Pearson J, Kagen LJ, Hamilton LL, Ramsey WH. Acute myoglobinuria associated with heroin addiction. JAMA 1971; 216; 1172-1176.
128. Ruttenber AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am. J. Forensic Med. Pathol. 1999; 20; 120-127.
129. Fahal IH, Sallomi DF, Yaqoob M, Bell GM. Acute renal failure after ecstasy. BMJ 1992; 305; 29.
130. Lehmann ED, Thom CH, Croft DN. Delayed severe rhabdomyolysis after taking 'ecstasy'. Postgrad. Med. J. 1995; 71; 186-187.
131. Chu PS-K, Ma W-K, Wong SC-W et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int. 2008; 102; 1616-1622.
132. Reuhl J, Bachl M, Schneider M, Lutz F, Bratzke H. Morphometric assessment of testicular changes in drug-related fatalities. Forensic Sci. Int. 2001; 115; 171-181.
133. Daling JR, Doody DR, Sun X et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 2009; 115; 1215-1223.
134. Büttner A. The neuropathology of drugs abuse. Neuropathol. Appl. Neurobiol. online: 6 OCT 2010 03:35AM EST | DOI: accessed on 6/12/2010 at (ISSN)1365-2990/accepted.
135. Smith C, Forrest ARW. Alcohol, drugs and toxins. In Whitwell H ed. Forensic neuropathology. London: Hodder Arnold, 2005; 168-179.
136. Klonoff DC, Andrews BT, Obana WG. Stroke associated with cocaine use. Arch. Neurol. 1989; 46; 989-993.
137. Petitti DB, Sidney S, Quesenberry C et al. Stroke associated with cocaine or amphetamine use. Epidemiology 1998; 9; 596-600.
138. Konzenn JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloid cocaine. Stroke 1995; 26; 1114-1118.
139. Nanda A, Vannemreddy P, Willis B, Kelley R. Stroke in the young: relationship of active cocaine use with stroke mechanism and outcome. Acta Neurochir. Suppl. 2006; 96; 91-96.
140. Neiman J, Haapaniemi HM, Hillbom M. Neurological complications of drug abuse: pathophysiological mechanisms. Eur. J. Neurol. 2000; 7; 595-606.
141. Büttner A, Mall G, Penning R, Sachs H, Weis S. The neuropathology of cocaine abuse. Leg. Med. 2003; 5; 240-242.
142. McGee SM, McGee DN, McGee MB. Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation. Am. J. Forensic Med. Pathol. 2004; 25; 334-337.
143. Ho EL, Josephson SA, Lee HS, Smith WS. Cerebrovascular complications of methamphetamine abuse. Neurocrit. Care 2009; 10; 295-305.
144. Fressler RD, Esshaki CM, Stankewitz RC, Johnson RR, Diaz FG. The neurovascular complications of cocaine. Surg. Neurol. 1997; 49; 339-345.
145. Nnadi CU, Mimiko OA, McCurtis HL, Cadet JL. Neuropsychiatric effects of cocaine use disorders. J. Natl Med. Assoc. 2005; 97; 1504-1515.
146. Habal R, Sauter D, Olowe O, Daras M. Cocaine and chorea. Am. J. Emerg. Med. 1991; 9; 618-620.
147. Daras M, Koppel BS, Atos-Radzion E. Cocaine-induced choreoathetoid movements ('crack dancing'). Neurology 1994; 44; 751-752.
148. Catalano G, Catalano MC, Rodriguez R. Dystonia associated with crack cocaine use. South. Med. J. 1997; 90; 1050-1052.
149. Fines RE, Brady WJ, DeBehnke DJ. Cocaine-associated dystonic reaction. Am. J. Emerg. Med. 1997; 15; 513-515.
150. Koppel BS, Samkoff L, Daras M. Relation of cocaine use to seizures and epilepsy. Epilepsia 1996; 37; 875-878.
151. Davis GC, Williams AC, Markey SP et al. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1979; 1; 249-254.
152. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219; 979-980.
153. Mash DC, Duque L, Pablo J et al. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Sci. Int. 2009; 190; e13-e19.
154. Büttner A, Mall G, Penning R, Weis S. The neuropathology of heroin abuse. Forensic Sci. Int. 2000; 113; 435-442.
155. Wolters EC, van Wijngaarden GK, Stam FC et al. Leucoencephalopathy after inhaling 'heroin' pyrolysate. Lancet 1982; 2; 1233-1237.
156. Tan TP, Algra PR, Valk J, Wolters EC. Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings. Am. J. Neuroradiol. 1994; 15; 175.
157. Kriegstein AR, Armitage BA, Kim PY. Heroin inhalation and progressive spongiform leukoencephalopathy. N. Engl. J. Med. 1997; 336; 589-590.
158. Salgado RA, Jorens PG, Baar I, Cras P, Hans G, Parizel PM. Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings. Am. J. Neuroradiol. 2010; 31; 565-566.